Skip to content

Bio-Rad Laboratories

US · BIO #1479 by market cap Listed 1970
358.90 -8.60 -2.34%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
A-
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 0 upgrades vs 1 downgrade among tracked analyst rating changes.
  • Most recent: Citi moved from Buy to Hold on 2026-04-07.

Analyst consensus 1 analysts

Buy
Avg price target 440.00 +22.6%
Price target rangecurrent 358.90
Low440.00
Avg440.00
High440.00
Buy 100% Hold 0% Sell 0%
Recent ratings (14)
DateFirmAnalystRatingTarget
2026-11-04 RBC Capital -- Buy 440.00
2026-09-27 RBC Capital -- Buy 390.00
2026-08-06 RBC Capital -- Buy 390.00
2026-08-04 RBC Capital -- Buy 370.00
2026-05-22 Wells Fargo -- Hold 310.00
2026-05-14 RBC Capital -- Buy 320.00
2026-05-01 Wells Fargo -- Hold 290.00
2026-04-07 Citi -- Hold 300.00
2026-02-16 Wells Fargo -- Hold 320.00
2026-02-13 UBS -- Buy 335.00
2026-02-12 Citi -- Buy 375.00
2025-12-15 Wells Fargo -- Hold 340.00
2025-10-30 Wells Fargo -- Hold 340.00
2025-10-30 Citi -- Buy 375.00

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-04-07 Citi Buy → Hold 300.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-04 After close ±8.45% -2.89% (in line)
2026/Q2 2026-08-04 After close ±8.42% +4.50% (in line)
2026/Q1 2026-04-30 After close ±9.56% -8.41% (in line)
2025/Q4 2026-02-12 After close ±10.41% -12.26% (beat)
2025/Q3 2025-10-29 After close ±8.35% -4.65% (in line)
2025/Q2 2025-07-31 After close ±14.92% +17.63% (beat)
2025/Q1 2025-05-01 After close ±8.31% -1.70% (in line)
2024/Q4 2025-02-13 After close ±8.13% -9.53% (beat)
2024/Q3 2024-10-30 After close ±11.39% +8.35% (in line)
2024/Q2 2024-08-01 After close ±8.24% -1.56% (in line)
2024/Q1 2024-05-07 After close ±8.07% -4.16% (in line)
2023/Q4 2024-02-15 After close ±8.93% +3.59% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Bio-Rad Laboratories discussion 0 comments

Add a comment